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The DNA amplification performed by terminal protein-primed repli-
cation systems has not yet been developed for its general use to
produce high amounts of DNA linked to terminal protein (TP). Here
we present a method to amplify in vitro heterologous DNAs using
the Φ29 DNA replication machinery and producing DNA with TP
covalently attached to the 5′ end. The amplification requires four
Φ29 proteins, DNA polymerase, TP, single-stranded DNA binding
protein and double-stranded DNA binding protein (p6). The DNA
to be amplified is inserted between two sequences that are the
Φ29 DNA replication origins, consisting of 191 and 194 bp from
the left and right ends of the phage genome, respectively. The
replication origins do not need to have TP covalently attached
beforehand to be functional in amplification and they can be joined
to the DNA to be amplified by cloning or ligation. The facts that
two functional origins were required at the ends of a linear tem-
plate DNA and that the kinetics of DNA synthesis was very similar
to that obtained using the TP-containing Φ29 genome as template
support the proposal that genuine amplification is taking place.
Amplification factors of 30-fold have been obtained. Possible
applications of DNAs produced by this method are discussed.
Φ29 DNA polymerase ∣ origins of replication
Although the most common systems to start DNA replicationare those in which a DNA or an RNA molecule is used as
primer, DNA synthesis can also be started using a protein as
primer. This type of system initiates DNA synthesis using as an
acceptor of the first dNMP, the OH group of a specific serine,
threonine, or tyrosine residue of a protein, instead of the 3′ OH
group of a ribose or deoxyribose (1). This protein is generally
named terminal protein (TP) because it becomes covalently
attached at the 5′ termini of the DNA. The TP-primed DNA
replication has been studied in a number of systems, such as
bacteriophages Φ29, Nf, and GA-1 (2), PRD1 (3), and Cp-1 (4),
linear plasmids from bacteria such as pSCL and pSLA2 (5), and
in adenovirus (6). In addition, TP-containing DNAs have been
identified in linear plasmids of mitochondria, yeast, and plants
and in bacterial chromosomes (Streptomyces sp.) (see ref. 1 for
a review). From all these, the bacteriophage Φ29 TP-DNA repli-
cation system has emerged as the best studied one (7). In vivo-
based methods to generate linear DNAs with TP attached at the
5′ ends have been described for Streptomyces plasmids (8) and
adenovirus (9). These methods take advantage of the observation
that a DNA containing the correct terminal sequences but not
having TP linked at the ends is capable, after transformation
of an appropriate host and selection, to produce inside the cell
the corresponding TP-DNA that is stably maintained. However,
to date none of these systems has been used to produce TP-DNAs
in high amounts appropriate for different molecular biology uses
(see below). Regarding the in vitro approaches, as of today, the
most efficient system has proved to be the Φ29 DNA replication
one. To our knowledge, no other in vitro system produces TP-
DNA amplification in high amounts using purified proteins (10).
TheΦ29 genome replication system is a very efficient TP-DNA
synthesizing machinery whether working in vitro or in vivo, pro-
vided that it is using as template the bacteriophage Φ29 DNA
with TP covalently attached to its 5′ ends (11, 12). The Φ29 in
vitro minimal amplification system of TP-DNA is based on four
essential components, DNA polymerase, TP, double-stranded
DNA binding protein p6, and single-stranded DNA binding pro-
tein (SSB) p5 (10). In the Φ29 DNA replication mechanism (13)
(Fig. S1), the origins of replication are the 5′ TP-linked ends of
the phage genome. These terminal regions have signals for the
cooperative binding of protein p6, which stimulates the initiation
of replication likely by opening the two strands of the DNA at the
very ends of the genome (14). The heterodimer formed by TP and
DNA polymerase (15) is recruited to the origin in a process
enhanced by the 5′-linked TP (parental TP) (16). Then, the in-
itiation of replication takes place in which the TP is used as a
primer by the DNA polymerase followed by a transition stage
when the polymerase synthesizes 10 nucleotides, dissociates from
the TP, and switches to the DNA-primed elongation mode of
replication until it reaches the end of the genome (17). The Φ29
DNA polymerase is endowed with a potent strand displacement
activity and a high processivity that allows it to perform the 19-kb
replication of the phage genome from a single binding event and
without the need for any accessory factors (12). The Φ29 replica-
tion system has been reported to amplify the genome of the phage
(TP-DNA) to microgram amounts starting from nanograms in a
single-step isothermal reaction (10). It is also important to note
that the amplification of the 19-kb phage DNA takes place with
high fidelity yielding fully functional DNA (10).
Until now, no systematic attempt had been made to produce
defined TP-linked heterologous DNAs in a fashion similar to the
amplification of the phage Φ29 genome. Here we report an in
vitro method to produce DNA with TP covalently attached to
the 5′ end that is not dependent on replication in a host cell
and has the potential to amplify DNAs of at least 18 kb of length.
The method defines the minimal sequences and requirements
that the origins should meet to be targets of amplification by
the Φ29 replication system.
Results and Discussion
Design of a Plasmid Displaying Functional Ends of the Φ29 Genome
After Linearization. Previous results showed that the initiation
of replication from templates having Φ29 DNA ends without
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TP was much less efficient than the initiation performed using
the Φ29 TP-DNA as template (16). Notwithstanding, there were
no experiments in which a comparison had been made between
the Φ29 genome (TP-DNA) and other templates having two Φ29
DNA terminal regions without TP, with respect to in vitro ampli-
fication using the Φ29 replication machinery as described (10).
For a template to be susceptible to amplification using the Φ29
system, it must have two fully functional Φ29 DNA ends that are
correctly oriented. To test whether it was possible to obtain am-
plification starting from adequate DNA templates that do not
have the parental TP covalently linked at the 5′ ends, the plasmid
described in Fig. 1A was designed. This plasmid, named pETOR-
PHI, contains the Φ29 DNA left and right ends up to base pairs
191 and 194, respectively (see below), a pUC-type replication ori-
gin, a kanamycin resistance marker, and two multicloning sites.
The Φ29 DNA ends are cloned with the extremities joined, in
inverted orientation, in such a way that a DraI restriction site is
created (Fig. 1B), and this site is unique in the plasmid. After
restriction of the plasmid with DraI, the two ends of the linear-
ized plasmid are identical to the two ends of Φ29 DNA up to the
mentioned positions (Fig 1C). The Φ29 DNA segments were
chosen to span the minimal functional origins as characterized
by in vitro experiments comprising the p6 nucleation sequences
(18) and the last 12 base pairs from each end (19) which include
the 6 bp inverted repeat (5′AAAGTA) with the AAA sequence of
the very end required for the sliding-back mechanism of initiation
of replication (20). Although the minimal origins are reported to
be 68 bp for the left end and 125 bp for the right end (18), in our
initial construct we lengthened the Φ29 DNA sequences up to
positions 191 and 194 from the left and right ends, respectively,
because those are the approximate distances at which the binding
of p6 to the Φ29 genome ends starts to become weaker (18).
Linearized pETORPHI Plasmid is Efficiently Replicated in Vitro by the
Φ29 DNA Synthesis Machinery. The ability of plasmid pETORPHI
(5.8 kb) cut with DraI (from now on pETORPHI) to support
TP-primed replication/amplification with the Φ29 replication
system was tested. As shown in Fig. 2A, in the presence of p6,
synthesis of TP-DNA took place as indicated by the accumulation
of 32P-labeled material at the right position (19.2 kb); the reaction
had reached a plateau starting with 25 ng of TP-DNA with little
increase in the amount of final product when using 100 ng as tem-
plate. When pETORPHI was used as template, in the presence of
p6, there was also accumulation of correct-sized 5.8-kb product;
the reaction was also at plateau-level using 25 ng of template. In
the absence of p6, there was synthesis of TP-DNA, although, with
25 ng of template, the reaction did not reach the maximum level
obtained with p6. On the other hand, when pETORPHI was used
as template, DNA synthesis turned out to be almost totally
dependent on the presence of p6. As a control, DNA synthesis
directed from the two templates was completely dependent on
TP (Fig. 2B), which means that all the DNA produced is initiated
by TP-priming and thus it contains TP linked at the end.
TheΦ29 Replication System Produces True Amplification from Plasmid
Templates. To determine whether true amplification products
were obtained, pETORPHI cut with DraI was further cut with
either MluI or PvuI giving rise in each case to two DNA mole-
cules of different size (see Fig. 1C). The two DNA fragments pro-
duced after restriction with MluI or PvuI could not be susceptible
to exponential amplification because each DNA molecule would
have only one of the Φ29 DNA origins and could only produce
linear replication. Fig. 3 shows that, in any of the cases in which
the two ends of the plasmid were separated, the amount of DNA
Fig. 1. Construction of a plasmid that generates the Φ29 DNA replication
origins upon linearization. (A) The pETORPHI plasmid contains fused frag-
ments of 191 and 194 bp from the left and right ends, respectively, of the
Φ29 genome. Left Ori and Right Ori stand for left and right Φ29 DNA origins,
respectively. (B) The ends were synthesized with an inverted “end-to-end”
orientation that generates a DraI site at the joining point as shown in the
figure. (C) Linearization of the plasmid with DraI produces the DNA segment
shown with the Φ29 ends in the correct orientation. MCS1 and MCS2 denote
multiple cloning sites 1 and 2; the sequences of the MCSs are listed in SI Text.
Fig. 2. The plasmid pETORPHI is an efficient template for DNA synthesis.
(A) The assays were done as described in Materials and Methods using the
amounts in nanograms of plasmid pETORPHI or Φ29 TP-DNA templates indi-
cated in the figure. The absence or presence of p6 in the reactions is indi-
cated. The size of the amplified bands is shown: 19.2 kb for Φ29 TP-DNA
and 5.8 kb for pETORPHI cut with DraI. Lambda phage DNA cut with HindIII
is shown as molecular weight marker (Mr). (B) The presence of TP is essential
for amplification. The assay was performed as in A, but using p6 in all cases.
The absence or presence of TP is indicated.
Fig. 3. The plasmid-templated amplification requires two Φ29 DNA ends
in the same molecule. The pETORPHI plasmid was cut with the indicated
enzymes under the conditions described in Materials and Methods. The
amounts in ng of Φ29 TP-DNA and plasmid fragments utilized in the ampli-
fication reactions are shown. The bands corresponding to the plasmid cut
with MluI or PvuI in addition to DraI are 4.6 and 4.4 kb, respectively.
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synthesized decreased greatly (between 10- and 20-fold, depend-
ing on the cases, as quantitated by phosphoimager), compared
with that obtained with the linearized pETORPHI. Even when
the fragments produced after restriction with the two enzymes
were mixed in the reaction, to check if they can hybridize or com-
plement each other (lane pETORPHI DraMluþDraPvu), the
outcome was the same as the cases in which fragments cut with
just one enzyme were used. As expected, the uncut plasmid gave
no signal. The conclusion of these experiments is that the plasmid
is undergoing true amplification utilizing the Φ29 DNA replica-
tion origins at both ends of the molecule.
To further ensure that the products generated by reactions
using the linearized pETORPHI plasmid as template are bona
fide amplification products, time-course amplification experi-
ments were performed and the results obtained with TP-DNA or
pETORPHI as templates were compared. Fig. 4A shows that
for the two templates a similar pattern was obtained, with the
maximum reached at 120 min (see Fig. S2 for quantitation of
the kinetics). If the amounts of DNA synthesized are normalized,
taking the values at 60 min as 100%, both templates, the Φ29
TP-DNA and pETORPHI, follow almost identical, nonlinear,
amplification kinetics (Fig. 4B). Given that the Φ29 TP-DNA
undergoes genuine amplification (10), the time-course results
support the proposal that pETORPHI is also being amplified.
The average amplification factors across experiments were 83
19 SD for the phage genome and 30 7 SD for the plasmid,
starting from 25 ng of template in both cases, which corresponds
to about 2 and 0.8 μg, respectively, of total DNA synthesized.
Minimal Template Requirements of the System.The minimal amount
of template that can be used as input in the amplification reaction
was determined. Fig. 5 shows that when the Φ29 TP-DNA is
used as template the minimal amount that allows amplification
is 10 ng and the maximal amount of product yielded is reached
at 17.5 ng, indicating that the reaction is close to saturation at that
point. When pETORPHI is used as template, the results are very
similar, 17.5 ng being the amount of template needed to reach
saturation. It should be noticed that the minimal amount of
template that produces amplification does not correspond to
the same initial number of molecules for pETORPHI and Φ29
TP-DNA, but to the same mass of DNA, which corresponds to
3.3 times more molecules of pETORPHI than those of TP-DNA.
The minimal length of Φ29 DNA that supports p6-stimulated
replication activity corresponds to the last 68 bp from the left end
of the Φ29 genome (18). As explained above, this DNA includes
the 6 bp inverted terminal repeat (5′ AAAGTA) and sequences
from base pairs 35–58 from the left end that have been described
as high affinity p6 binding sites (18, 21). For the right end of Φ29
DNA, the minimal origin is longer, 125 bp, and the p6 affinity se-
quences are not as precisely defined as those of the left end (18).
Thus, as a first step to develop an amplification system based on a
minimal origin, we tested whether a fragment of 68 bp from the
left Φ29 DNA end is capable of supporting amplification. The
194-bp segment corresponding to the right end of theΦ29 genome
from pETORPHI was replaced by the 68-bp minimal origin from
the left end described above, to obtain pETORPHI68L (Fig. S3
and SI Text). The 68-bp fragment was cloned in inverted orienta-
tion as in pETORPHI allowing the generation of the Φ29 DNA
ends upon linearization with DraI. As shown in Fig. 5 (Right) the
amount of pETORPHI68L that serves as template for amplifica-
tion is the same as that of the original pETORPHI; however, the
final amount of product obtained with pETORPHI68L is lower
(29 8% SD with respect to pETORPHI).
Two Different Strategies to Produce Heterologous TP-DNAs.We have
shown that the plasmid pETORPHI, after linearization with the
enzyme DraI, presents two functional origins of replication for
the Φ29 minimal amplification machinery. The fact that the DraI
site occurs very often in vectors and genomes with a medium to
high ATcontent could constitute a problem if more DraI sites are
present in the vector or in the DNA to be amplified. To overcome
this problem, a procedure was designed to cut the pETORPHI
plasmid in such a way that Φ29 DNA ends are generated using
a restriction site different from that recognized by DraI. We chose
the enzyme BaeI because its recognition site is much more rare
in all kinds of DNAs as compared to the DraI site and it leaves
ends compatible with the Φ29 DNA origins (Fig. 6A). Thus, a
plasmid called pEYFPORBae was constructed (see SI Text) such
that a BaeI restriction site was inserted at the junction between
the Φ29 DNA ends from pETORPHI. BaeI cuts at two different
points in each strand of the DNA, separated by 33 bp, having its
recognition site in the middle and cutting the DNA indepen-
dently of the sequence at the corresponding scission points.
The cut with BaeI leaves 3′ extensions of five nucleotides at the
resulting ends (Fig. 6A). Until now the effect of the 3′ extensions
Fig. 4. The amplification kinetics of pETORPHI is similar to that of Φ29
TP-DNA. (A) Reactions containing 25 ng ofΦ29 TP-DNA or pETORPHI cut with
DraI were allowed to proceed at 22 °C for the indicated times and then they
were stopped by addition of SDS to 0.1% and EDTA to 10 mM. (B) The
amounts of synthesized DNA, expressed as a percentage of the value reached
at 60 min, was represented as a function of time for reactions with Φ29
TP-DNA (▴) or pETORPHI (⦁) as templates. The bars represent the standard
deviations from three independent experiments.
Fig. 5. Minimal amount of template required for amplification. The ampli-
fication reactions were set up with the indicated amounts in nanograms of
Φ29 TP-DNA or pETORPHI plasmid cut with DraI. The pETORPHI68L (see
Materials and Methods and Fig. S2) was cut with DraI and the experiment
was performed as before with the indicated amounts of template (Right).
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attached to the Φ29 DNA origins on the amplification efficiency
of the Φ29 replication machinery had not been reported and,
therefore, three different approaches for the amplification
reaction were tried: (i) performing the reaction under standard
conditions after BaeI treatment (lane pEYFPORBae); (ii) pre-
treatment of the BaeI-cut plasmid with theΦ29 DNA polymerase
in the presence of dNTPs to eliminate the 3′ extensions, and then
adding the TP and the rest of the components of the reaction
(lane pEYFPORBae-Pretreat); and (iii) pretreatment with the
Klenow polymerase and dNTPs, also to generate blunt ends,
and then adding the components to set a standard Φ29 DNA am-
plification reaction (lane pEYFPORBae-Klenow). As shown in
Fig. 6B, the DNA yield with approaches i and iii was 50% of that
obtained with the original pETORPHI. The pretreatment with
the Φ29 DNA polymerase produced a lower amount of DNA,
perhaps due to the strong exonuclease activity of this enzyme.
As a control, when pEYFPORBae cut with BaeI was further
cut with SacII to separate the two origins, the amount of product
obtained was greatly decreased (Fig. S4).
Having shown above that a fragment of 68 bp from the left end
origin of Φ29 DNA is a functional amplification origin, we can
design single-stranded oligonucleotides that, after hybridization,
will generate the 68-bp fragment as dsDNA plus any extra se-
quence of interest, for example, single-stranded extensions to be
ligated to foreign DNA ends obtained after digestion with restric-
tion enzymes. By this procedure, one can generate Φ29 DNA
“adapters” that join the Φ29 minimal origin to any linear DNA
to be amplified with the Φ29 replication system. To test this
approach, we introduced by site-directed mutagenesis a BsmBI
site in plasmid pEYFP-N1 at position 4702. Then the pEYFP-
N1Bsm plasmid was cut with the enzymes BsmBI and EcoO109I,
which recognize unique sequences in that vector. We also used
two sets of single-stranded synthetic oligonucleotides so that,
after hybridization, each set would form the double-stranded
68-bp Φ29 minimal origin plus short single-stranded DNA exten-
sions to ligate specifically to one of the two ends of pEYFP-
N1Bsm obtained after restriction with BsmBI and with EcoO109I
(Fig. 7A). The enzymes were chosen because they generate
asymmetric ends, preventing self-ligation of the oligonucleotides
bearing the half-site cohesive end and cross-ligation between the
BsmBI and EcoO109I sites. In this way, each set of oligonucleo-
tides, after hybridization, can ligate with the complementary
restriction end of the plasmid but not with the other end, with the
other set of oligonucleotides, or self-ligate. In addition, this
approach makes it unnecessary to gel purify the DNA fragments
or the ligation products. The use as template for amplification
of the DNAs resulting from the ligase reaction would only allow
true amplification from one of the ligation products, which is the
3,885-bp plasmid fragment (Fig. 7A) ligated to the two different
68-bp Φ29 DNA adapters. This product would generate a band
of 4,021 bp corresponding to Φ29_68L-BsmBI-pEYFP-N1_frag-
ment 1-EcoO109I-Φ29_68L′. The other fragment (fragment 2)
would not be ligated to the adapters and thus would not be
amplified. As shown in Fig. 7B, only the ligation containing all
the correct components generates an amplified band of the right
length (lane 68L-DNA-68L′), whereas reactions performed with
ligation mixtures lacking one adapter (68L-DNA) gave clearly
less signal, and control reactions containing only the adapters
(68L-68L′) did not yield any amplified product. The band of high-
er molecular weight (4.6 kbp) that appears when 68L-DNA-68L′
or 68L-DNA are used as templates corresponds to plasmids
cut with one enzyme and ligated to one type of adapter; these
molecules should not serve as templates for amplification. Bands
of lower molecular weight were detected, especially in the case of
the DNA ligated with one adapter (68L-DNA). Low molecular
weight DNA has been characterized as truncated molecules that
Fig. 6. A pETORPHI derivative linearized with BaeI is efficient in amplifica-
tion. (A) Scheme of BaeI recognition (underlined) and cutting sites (arrows)
and position of Φ29 origins (capital letters) in pEYFPORBae. (B) Plasmid
pEYFPORBae was prepared as described in Materials and Methods. Aliquots
of 25 ng of pEYFPORBae cut with the enzyme BaeI (from now on pEYFPOR-
Bae) were included in the different reactions as templates. The amplification
reactions were set up as usual (lane pEYFPORBae), or by pretreating the di-
gested plasmid 10 min with Φ29 DNA polymerase and 100 μM dNTPs and
then adding TP (pEYFPORBae-Pretreat), or pretreating the plasmid 10 min
with the Klenow enzyme and 30 μM dNTPs, inactivating the enzyme, and
then adding the rest of the components of the reaction (pEYFPORBae-
Klenow). The size of the amplified bands is shown: 5.8 kb for pETORPHI cut
with DraI and 5.3 kb for pEYFPORBae cut with BaeI.
Fig. 7. Ligation of 68 bp from the Φ29 genome left end at the two ends of
a heterologous DNA fragment supports amplification. (A) Scheme of DNA
fragments present in the ligation reactions. The 68-bp Φ29 left end origins
were assembled from single-stranded oligonucleotides bearing cohesive
ends for the enzymes BsmBI (68L) or EcoO109I (68L′) as described in the text.
The plasmid pEYFP-N1Bsm was cut with BsmBI and EcoO109I, generating
the two fragments (1 and 2) indicated in the figure. Only fragment 1 has
cohesive ends compatible with the Φ29 linkers. (B) Ligations were set up with
either just one of the adapters plus the plasmid fragments 1 and 2 (see
Materials and Methods) (lanes 68L-DNA), the two adapters 68L and 68L′, and
the plasmid fragments (lanes 68L-DNA-68L′), or with the two types of adap-
ters alone (68L-68L′). An aliquot of sample 68L-DNA-68L′ was left untreated
with T4 polynucleotide kinase (PNK) (lanes 68L-DNA-68L′-P) (see Materials
and Methods). Aliquots (0.5 or 1 μL) of the ligation mixtures were used as
templates in the amplification reactions. (C) Aliquots of pETORPHI were
either untreated (pETORPHI), treated with Antarctic Phosphatase (þ Pase),
with PNK after the phosphatase (þPaseþ PNK), or processed in the same
way as the treated samples but without added enzymes (pETORPHI*). In
all cases, the amount of pETORPHI in the reactions was 25 ng. The size of
pETORPHI cut with DraI is 5.8 kb and the 68L-DNA-68L′ is 4.0 kb.
18658 ∣ www.pnas.org/cgi/doi/10.1073/pnas.1114397108 Mencía et al.
become palindromic and so they acquire a duplicated replication
origin (22). The results obtained show that it is possible to ligate
Φ29 DNA minimal origins to a heterologous DNA to get TP-
DNA of the right length amplified by the Φ29 replication system.
Fig. 7B also shows that, when 5′ unphosphorylated oligonucleo-
tides were used (lanes 68L-DNA-68L′-P), very low amplification
was obtained. To confirm the importance of the 5′ phosphate
group in amplification, the experiment shown in Fig. 7C was
carried out. When pETORPHI cut with DraI was treated with
Antarctic Phosphatase almost no amplification was obtained.
Further treatment with T4 polynucleotide kinase restored the
amplification close to the level obtained with pETORPHI or with
pETORPHI treated as control.
As mentioned before, no studies to develop in vitro TP-primed
amplification of heterologous DNAs had been reported. Previous
results showed that it was possible to initiate replication using
dsDNAs that contain the ends of the genome without TP at-
tached; however, the efficiency of the initiation/replication of
these DNAs was much lower than that of the phage TP-DNA
(20). In this work, we have shown that it is possible to obtain
efficient amplification in vitro with the Φ29 DNA replication
machinery using as template a linear DNA displaying Φ29 DNA
replication origins, but not having the parental TP covalently
linked at their ends. Two lines of evidence support the notion that
the Φ29 system is producing true DNA amplification: One, the
fact that the separation in two different molecules of the two Φ29
DNA origins greatly reduces the amount of product, and two, the
kinetics of the reaction using pETORPHI as template is very
similar to that obtained with TP-DNA as template. As shown
in Fig. S5B, the DNA that can be inserted between the Φ29 ori-
gins for amplification is at least 18 kb. Furthermore, as mentioned
above, the Φ29 DNA polymerase is very processive and over
70 kb of continuous replication has been obtained (12). Thus, the
method we present here has the potential to perform very long
amplifications.
Regarding the parental TP, in this work we have shown that it
is not essential for amplification (Fig. 2A); however, it increases
the amount of amplified product obtained and decreases the
amount of template molecules needed. In addition, the amplifi-
cation of pETORPHI was very dependent on the presence of
p6, although that was not the case for TP-DNA under the experi-
mental conditions used.
The minimal requirements for the in vitro amplification system
in terms of proteins and DNA sequences are summarized in
Fig. S6. The DNA sequences correspond to the Φ29 minimal
68 bp left origin. This 68-bp origin contains the last 12 bp from
theΦ29 DNA end that are necessary for replication initiation and
elongation, and it also contains a high-affinity p6 binding site cor-
responding to nucleotides 35 to 58 from the end. The phosphate
group at position 5′ has also been shown to be a requirement
for amplification. Our results also show that the p6 nucleation
site is sufficient to obtain amplification in the presence of protein
p6 and the minimal origin sequences, although a higher yield is
obtained with the 194-bp origin.
The Φ29 system can efficiently generate amplified products
from templates that have five nucleotides protruding at the 3′
end, as it is the case of plasmid pEYFPORBae linearized with
BaeI. These 3′ end-protruding nucleotides were removed by the
exonuclease activity of Φ29 DNA polymerase that would gener-
ate blunt ends identical to the genuine Φ29 replication origins.
In order to expand the possibilities of the system, we have also
shown that the 68-bp minimal replication origin can be attached
to a foreign DNA by ligation and serve as amplification template.
The potential applications of a TP-primed amplification meth-
od based on the Φ29 replication system described here would be
of two types. One, there would be the possibility to amplify in a
defined way long linear DNAs, like viral genomes, chromosome
fragments, or plasmids. Because the amplified DNAs have TP
linked at the end, this TP can be removed, for example, by restric-
tion digestion at the DNA ends, if the protein is unwanted for
downstream applications. The other potential distinctive type of
application of the method described in this work would be to gen-
erate in vitro high amounts of DNAs bound to TP for uses in
which a hybrid protein–DNA molecule is required. One example
of that would be the use of protein–DNA molecules as gene de-
livery vehicles, such that the DNA would be targeted to specific
cells, ferried to subcellular compartments, and protected from
exonucleases by the covalently linked protein in such a way that
the TP is acting as a platform to which different targeting peptide
modules are fused. In this sense, a previous report has shown
that the expression of a CFP-TP fusion protein in vivo comple-
ments an infecting phage Φ29 mutant that cannot express the TP,
indicating that fusion of proteins at the TP N terminus may not
impair the TP function (23). Another use of the protein–DNA
molecules could be based in the generation of enzyme-DNA ap-
tamer hybrids that could exploit the advantages of both types of
molecules. The enzyme would be fused to the TP that is utilized
as a primer to amplify a short DNA that contains a sequence that
folds into an aptamer-type structure. In the amplification process,
multiple copies of the enzyme-TP would be linked to the aptamer-
DNA synthesized. In the protein/DNA molecule (enzyme-TP/
aptamer), the aptamer could recruit a given substrate on which
the enzyme component would perform a specific reaction.
Regarding the biological activity of DNAs amplified with the
TP-based Φ29 system, previous work showed that the quality of
a TP-containing Φ29 DNA amplified in vitro in the presence of
the minimal set of replication proteins (TP, DNA polymerase,
SSB, and p6) is identical to the TP-containing DNA isolated from
phage particles measured as the ability to produce viral progeny
in a Bacillus subtilis protoplasts transfection assay (10). This
supports the possible use of the system described in this paper
to generate TP-DNAs with biological activity.
Concluding Remarks. In summary, we describe a method to pro-
duce by amplification DNAs with TP covalently attached to the
5′ end using the in vitro Φ29 DNA replication system that in-
cludes four proteins and the DNA replication origins. Functional
DNA origins do not need to have TP linked beforehand, can be
between 194- and 68-bp long, can have protruding 3′ ends, and
they require a phosphate group at the 5′ end. This method opens
up possibilities in relation to amplification of DNA and the gen-
eration of hybrid protein–DNA molecules.
Materials and Methods
Nucleotides and DNAs. Unlabeled nucleotides were purchased from General
Electric Healthcare, and ½α-32PdATP [3;000 Ci∕mmol (1 Ci ¼ 37 GBq)] was
obtained from Amersham Pharmacia. Oligonucleotides were obtained from
Sigma-Genosys. Φ29 TP-DNA was prepared as described (24).
A DNA fragment consisting of DNA sequences corresponding to 191 and
194 bp from the left and right ends, respectively, of the Φ29 genome joined
through the Φ29 DNA ends was obtained from Genescript cloned in plasmid
pUC57 (pUC57ORPHI). The pETORPHI plasmid was constructed by cloning
between sites SacI and HindIII of pET28b (Novagen) a DNA fragment excised
from pUC57ORPHI using the same restriction enzymes. In this way the pETOR-
PHI gets a unique DraI site, which is the one formed at the exact joint
between the Φ29 origins of replication. Construction of plasmids pETOR-
PHI68L, pETORPHIBae, and pEYFPORBae is described in SI Text. Digestion
of the plasmids with the enzyme DraI was normally performed for 4 h at
37 °C in New England Biolabs Buffer 4 except for the cases where multiple
digestions with enzymes DraI, MluI, and PvuI had to be made; in this case,
New England Biolabs Buffer 3 plus 0.1 mg∕mL of BSA were used. Digestion
of plasmid pEYFPORBae with BaeI was done in New England Biolabs Buffer 4
supplemented with 0.1 mg∕mL of BSA and 20 μM S-adenosylmethionine.
After digestion with BaeI, the DNA was purified by Qiaquick Spin columns
(Qiagen). All the enzymes were inactivated by incubating at 65 or 80 °C
depending on the case. In all cases, the restriction cuts were confirmed by
agarose gel electrophoresis. In the experiments that involved ligations,
plasmid pEYFPBsm was cut with BsmBI and EcoO109I in New England Biolabs
Buffer 3 for 8 h at 37 °C, purified by Qiaquick Spin columns (Qiagen), and
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then ligated in a 1∶4 proportion to the corresponding double-stranded
hybridized oligonucleotides (oligonucleotides 68Lþ Comp68LBsm, 68Lþ
Comp68LEco109; see SI Text, Oligonucleotides List). After inactivation of
the ligase, the samples were treated with New England Biolabs T4 Poly-
nucleotide Kinase, without changing buffer, for 30 min at 37 °C. After inac-
tivation of the kinase, aliquots of the ligation reactions were used for
amplification without any other treatment. Dephosphorylation was per-
formed utilizing the Antarctic Phosphatase of New England Biolabs, adding
its corresponding buffer and incubating at 37 °C for 15 min and then inacti-
vating the enzyme by incubation for 20 min at 65 °C. After this treatment,
the samples were ethanol precipitated with 20 μg of glycogen as carrier
to eliminate the phosphatase buffer. After precipitation, the samples were
resuspended in New England Biolabs Ligase buffer and used directly in
the amplification experiments.
Protein Purification. DNA polymerase and SSB were purified as described in
Lázaro et al. (25) and Soengas et al. (26), respectively. TP and protein p6 were
purified as described in SI Text.
Amplification Assay. The incubation mixture contained, in 25 μL, Buffer MRI
1X [50 mM Tris·HCl (pH 7.5), 10 mM MgCl2, 5% glycerol, 1 mM DTT,
0.1 mg∕mL BSA] plus ammonium sulfate to 20 mM final concentration,
100 μM each of the four dNTPs plus ½α-32PdATP (1 μCi), 7.5 μg Φ29 SSB,
1.5 μg Φ29 p6, 10 ng Φ29 DNA polymerase, and 20 ng Φ29 TP unless other-
wise stated, and the indicated amounts of the corresponding type of DNA.
Reactions were allowed to proceed for 2 h at 22 °C and stopped by addition
of EDTA to 10 mM and SDS to 0.1% final concentrations, respectively. Then
the samples were filtered through Sephadex G-50 columns equilibrated
in 10 mM Tris·HCl (pH 7.5), 1 mM EDTA, and 0.1% SDS, and after that the
samples were dried, resuspended in 50 μL of 0.5 M NaOH, and analyzed
by electrophoresis in 0.7% agarose gels run in the presence of 30 mM NaOH
and 1 mM EDTA. A typical result out of at least three independent experi-
ments is shown. The radioactivity incorporated (cpm) was measured with
an LKB Wallac 1219 Rackbeta liquid scintillation counter. Quantitation of
gel bands was performed on BAS1000 phosphorimager equipment. The
synthesized DNA was determined calculating the ratio of radioactivity incor-
porated into DNA with respect to total radioactivity present in the reaction
and, using that ratio, the total mass of dNMPs incorporated into DNA was
calculated by multiplying the initial mass of dNTPs present in the reaction
by the ratio incorporated/total obtained from the radioactive nucleotide.
Lambda phage DNA cut with HindIII, used as molecular weight marker,
was labeled by incubation for 25 min at 25 °C with the Klenow enzyme
and 50 μM each of dCTP, dGTP, and dTTP plus ½α-32PdATP (1 μCi) in Buffer
EcoPol (New England Biolabs).
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